Article(id=1330225427009876072, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.04.018, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1636387200000, receivedDateStr=2021-11-09, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080056192, onlineDateStr=2026-11-19, pubDate=1649520000000, pubDateStr=2022-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080056192, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080056192, creator=13701087609, updateTime=1795080056192, updator=13701087609, issue=Issue{id=1330225302346773381, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='4', pageStart='347', pageEnd='484', issueExtLink='null', onlineDate='null', pubDate='1649520000000', pubDateStr='2022-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080026470, creator='13701087609', updateTime=1795084707533, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244936621994666, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244936621994667, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225302346773381, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=464, endPage=469, ext={EN=ArticleExt(id=1330225427190231145, articleId=1330225427009876072, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=The progression of topical agents for prevention and treatment of non-melanoma skin cancer, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Non-melanoma skin cancer (NMSC) is one of the most common cutaneous malignancies. With the aging of the population, the prevalence rate is getting higher and higher. With further research for pathogenesis of NMSC, some new topical agents have been emerging, and the clinical research on various topical agents for the treatment of NMSC and its precancerous lesions actinic keratosis has become more and more perfect. Through clinical trials, the efficacy of most external preparations has been further affirmed. This paper reviewed the mechanism, clinical application and side effects of NMSC external preparations for the treatment of actinic keratosis and NMSC to provide more reference for clinical treatment of NMSC.

, authors=Leimeng GAN1, 2, Yuchong CHEN2, *, authorsList=Leimeng GAN, Yuchong CHEN, authorCompany=null, correspAuthors=Yuchong CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225427399946346, articleId=1330225427009876072, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=外用制剂对非黑素瘤皮肤癌预防及治疗的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

非黑素瘤皮肤癌(non-melanoma skin cancer,NMSC)是一种最常见的皮肤恶性肿瘤。随着人口老龄化的进展,其患病率也越来越高。近年来,随着对NMSC发病机制的深入研究,一些新的治疗药物不断出现,各种治疗NMSC及其癌前病变光线性角化病的外用制剂临床研究也越来越完善。通过临床研究,大部分外用制剂的疗效得到进一步肯定。现就治疗光线性角化病和NMSC外用制剂的作用机制、临床应用及不良反应作一综述,为临床针对NMSC的治疗提供更多用药参考。

, authors=甘蕾萌1, 2, 陈裕充2, *, authorsList=甘蕾萌, 陈裕充, authorCompany=null, correspAuthors=陈裕充, authorNote=

甘蕾萌,硕士研究生,护师,研究方向:皮肤肿瘤并发症及护理。

, correspAuthorsNote=
陈裕充,医学博士,副主任医师,研究方向:皮肤肿瘤及毛发移植。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=CetjtjY1EQR1c36snc/npg==, magXml=f1F475WC9fUX8nkApFKTAg==, pdfUrl=null, pdf=6RlgHU+srzRkJjxassYi+A==, pdfFileSize=1752159, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=FbIdrdp+vYLenh66XNdK0Q==, mapNumber=null, fund=null)}, authors=[Author(id=1330225427764850802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225427844542581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427764850802, language=EN, stringName=Leimeng GAN, firstName=Leimeng, middleName=null, lastName=GAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of Nursing, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China
2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225427920040054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427764850802, language=CN, stringName=甘蕾萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.南华大学衡阳医学院护理学院,湖南 衡阳 421001
2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443, bio={"content":"

甘蕾萌,硕士研究生,护师,研究方向:皮肤肿瘤并发症及护理。

"}, bioImg=null, bioContent=

甘蕾萌,硕士研究生,护师,研究方向:皮肤肿瘤并发症及护理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225427584495723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=1., ext=[AuthorCompanyExt(id=1330225427592884332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427584495723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Nursing, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China), AuthorCompanyExt(id=1330225427601272941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427584495723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.南华大学衡阳医学院护理学院,湖南 衡阳 421001)]), AuthorCompany(id=1330225427655798894, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=2., ext=[AuthorCompanyExt(id=1330225427659993199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1330225427668381808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443)])]), Author(id=1330225427995537528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225428079423610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427995537528, language=EN, stringName=Yuchong CHEN, firstName=Yuchong, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225428154921083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427995537528, language=CN, stringName=陈裕充, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225427655798894, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=2., ext=[AuthorCompanyExt(id=1330225427659993199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1330225427668381808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443)])])], keywords=[Keyword(id=1330225428247195772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=EN, orderNo=1, keyword=non-melanoma skin cancer), Keyword(id=1330225428305916029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=EN, orderNo=2, keyword=actinic keratosis), Keyword(id=1330225428364636286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=EN, orderNo=3, keyword=topical gaents), Keyword(id=1330225428419162239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=EN, orderNo=4, keyword=treatment progress), Keyword(id=1330225428477882498, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=CN, orderNo=1, keyword=非黑素瘤皮肤癌), Keyword(id=1330225428549185667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=CN, orderNo=2, keyword=光线性角化病), Keyword(id=1330225428603711620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=CN, orderNo=3, keyword=外用制剂), Keyword(id=1330225428666626181, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, language=CN, orderNo=4, keyword=治疗进展)], refs=[Reference(id=1330225428758900870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Ottwell R, Cook C, Greiner B, et al. Lifestyle behaviors and sun exposure among individuals diagnosed with skin cancer: a cross-sectional analysis of 2018 BRFSS data[J]. J Cancer Surviv, 2021, 15(5): 792-798., articleTitle=null, refAbstract=null), Reference(id=1330225428826009735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review[J]. Br J Dermatol, 2017, 177(2): 350-358., articleTitle=null, refAbstract=null), Reference(id=1330225428905701512, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Hashim PW, Chen T, Rigel D, et al. Actinic keratosis: current therapies and insights into new treatments[J]. J Drugs Dermatol, 2019, 18(5): s161-166., articleTitle=null, refAbstract=null), Reference(id=1330225428977004681, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Hsu SH, Gan SD, Nguyen BT, et al. Ablative fractional laser-assisted topical fluorouracil for the treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ: a follow-up study[J]. Dermatol Surg, 2016, 42(9): 1050-1053., articleTitle=null, refAbstract=null), Reference(id=1330225429039919242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Collins A, Savas J, Doerfler L. Nonsurgical treatments for nonmelanoma skin cancer[J]. Dermatol Clin, 2019, 37(4): 435-441., articleTitle=null, refAbstract=null), Reference(id=1330225429098639499, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Jansen MHE, Kessels JPHM, Merks I, et al. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands[J]. Br J Dermatol, 2020, 183(4): 738-744., articleTitle=null, refAbstract=null), Reference(id=1330225429157359756, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Pomerantz H, Hogan D, Eilers D, et al. Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial[J]. J Am Med Assooc Dermatol, 2015, 151(9): 952-960., articleTitle=null, refAbstract=null), Reference(id=1330225429220274317, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Heuser CL, Heuser GG, Casagrande J, et al. Peeling with 70% glicolic acid followed by 5% 5-fluorouracil as well as 5% 5-fluorouracil cream are effective methods for the treatment of actinic keratoses on upper limbs: a randomized clinical trial[J]. Dermatol Ther, 2020, 33(3): e13459., articleTitle=null, refAbstract=null), Reference(id=1330225430851858574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Jain SK, Kaur M, Kalyani P, et al. Microsponges enriched gel for enhanced topical delivery of 5-fluorouracil[J]. J Microencapsul, 2019, 36(7): 677-691., articleTitle=null, refAbstract=null), Reference(id=1330225430960910479, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Hussain A, Samad A, Ramzan M, et al. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation[J]. Drug Deliv, 2016, 23(4): 1115-1129., articleTitle=null, refAbstract=null), Reference(id=1330225431019630736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Soong LC, Keeling CP. Cryosurgery + 5% 5-fluorouracil for treatment of superficial basal cell carcinoma and bowen's disease[J]. J Cutan Med Surg, 2018, 22(4): 400-404., articleTitle=null, refAbstract=null), Reference(id=1330225431103516817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Pomerantz H, Korgavkar K, Lee KC, et al. Validation of photograph-based toxicity score for topical 5-fluorouracil cream application[J]. J Cutan Med Surg, 2016, 20(5): 458-466., articleTitle=null, refAbstract=null), Reference(id=1330225431179014290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Maarouf M, Kromenacker BW, Brucks ES, et al. Reducing unpleasant side effects of topical 5-fluorouracil treatment for actinic keratosis: a randomized controlled trial[J]. J Dermatolog Treat, 2020, 31(2): 175-179., articleTitle=null, refAbstract=null), Reference(id=1330225431258706068, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Petrilli R, Eloy JO, Paschoal JAR, et al. Quantification of 5-FU in skin samples for the development of new delivery systems for topical cancer treatment[J]. Pharmazie, 2018, 73(3): 133-138., articleTitle=null, refAbstract=null), Reference(id=1330225431321620629, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Ondo AL, Kerner JD, Kerner JV, et al. Treatment of cutaneous squamous cell carcinoma in situ with curettage followed by topical imiquimod 5% cream[J]. Dermatol Surg, 2021, 47(5): 609-612., articleTitle=null, refAbstract=null), Reference(id=1330225431397118102, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Agozzino M, Russo T, Franceschini C, et al. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial[J]. Curr Med Res Opin, 2019, 35(10): 1785-1792., articleTitle=null, refAbstract=null), Reference(id=1330225431476809879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Arits AH, Mosterd K, Essers BA, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial[J]. Lancet Oncol, 2013, 14(7): 647-654., articleTitle=null, refAbstract=null), Reference(id=1330225431556501656, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Jia HX, He YL. Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial[J]. J Dermatolog Treat, 2020, 31(8): 831-838., articleTitle=null, refAbstract=null), Reference(id=1330225431627804825, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Sharma M, Sharma G, Singh B. Actinic keratosis and imiquimod: a review of novel carriers and patents[J]. Expert Opin Drug Deliv, 2019, 16(2): 101-112., articleTitle=null, refAbstract=null), Reference(id=1330225431686525082, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Singer K, Dettmer K, Unger P, et al. Topical diclofenac reprograms metabolism and immune cell infiltration in actinic keratosis[J]. Front Oncol, 2019, 9: 605., articleTitle=null, refAbstract=null), Reference(id=1330225431766216860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Čeović R, Petković M, Mokos ZB, et al. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient[J]. Clin Dermatol, 2018, 36(2): 177-187., articleTitle=null, refAbstract=null), Reference(id=1330225431875268766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Schmitz L, Gupta G, Segert MH, et al. Diclofenac sodium 3% in hyaluronic acid 2.5% gel significantly diminishes the actinic keratosis area and severity index[J]. Skin Pharmacol Physiol, 2018, 31(4): 206-211., articleTitle=null, refAbstract=null), Reference(id=1330225431946571935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Koch F, Salva KA, Wirtz M, et al. Efficacy of cold atmospheric plasma vs diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP)[J]. J Eur Acad Dermatol Venereol, 2020, 34(12): e844-e846., articleTitle=null, refAbstract=null), Reference(id=1330225432017875104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Brinkhuizen T, Frencken KJA, Nelemans PJ, et al. The effect of topical diclofenac 3% and calcitriol 3 mg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): a phase Ⅱ, randomized controlled trial[J]. J Am Acad Dermatol, 2016, 75(1): 126-134., articleTitle=null, refAbstract=null), Reference(id=1330225432072401057, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Heron CE, Feldman SR. Ingenol mebutate and the treatment of actinic keratosis[J]. J Drugs Dermatol, 2021, 20(1): 102-104., articleTitle=null, refAbstract=null), Reference(id=1330225432131121314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Lv R, Sun Q. A network meta-analysis of non-melanoma skin cancer (NMSC) treatments: efficacy and safety assessment[J]. J Cell Biochem, 2017, 118(11): 3686-3695., articleTitle=null, refAbstract=null), Reference(id=1330225432189841571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Chee JB, Park JT, Kim BR, et al. A case of Bowen's disease successfully treated with ingenol mebutate gel[J]. Ann Deramtol, 2017, 29(4): 523-524., articleTitle=null, refAbstract=null), Reference(id=1330225432248561828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Khalfe Y, Rosen T. Ingenol mebutate: expanded utility[J]. J Drugs Dermatol, 2020, 19(2): 156-161., articleTitle=null, refAbstract=null), Reference(id=1330225432311476389, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Alirezai M, Dupuy P, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses[J]. J Am Acad Dermatol, 1994, 30(3): 447-451., articleTitle=null, refAbstract=null), Reference(id=1330225432366002342, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Ianhez M, Pinto SA, Miot HA, et al. A randomized, open, controlled trial of tretinoin 0.05% cream vs low-dose oral isotretinoin for the treatment of field cancerization[J]. Int J Dermatol, 2019, 58(3): 365-373., articleTitle=null, refAbstract=null), Reference(id=1330225432454082727, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Bianchi L, Orlandi A, Campoine E, et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathogical study on a large series of cases[J]. Br J Dermato, 2004, 151(1): 148-156., articleTitle=null, refAbstract=null), Reference(id=1330225432512802984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Herold M, Good AJ, Nielson CB. Use of topical and systemic retinoids in solid organ transplant recipients: update and review of the current literature[J]. Dermatol Surg, 2019, 45(12): 1442-1449., articleTitle=null, refAbstract=null), Reference(id=1330225432579911849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Ianhez M. Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment[J]. Br J Dermatol, 2018, 179(5): 1026-1027., articleTitle=null, refAbstract=null), Reference(id=1330225432642826410, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Pommergaard HC, Burcharth J, Rosenberg J, et al. Topical treatment with diclofenac, calcipotriol (vitamin-D3 analog) and difluoromethylornithine (DFMO) does not prevent nonmelanoma skin cancer in mice[J]. Cancer Invest, 2013, 31(2): 92-96., articleTitle=null, refAbstract=null), Reference(id=1330225432705740971, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Cunningham TJ, Tabacchi M, Eliane JP, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy[J]. J Clin Invest, 2017, 127(1): 106-116., articleTitle=null, refAbstract=null), Reference(id=1330225432764461228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Micali G, Lacarrubba F, Bhatt K, et al. Medical approaches to non-melanoma skin cancer[J]. Expert Rev Anticancer Ther, 2013, 13(12): 1409-1421., articleTitle=null, refAbstract=null), Reference(id=1330225432823181485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Puviani M, Milani M. Treatment of grade Ⅱ and Ⅲ actinic keratosis lesions with a film-forming medical device containing sunscreen/piroxicam 0.8% and a retinoic acid/glycolic gel: a pilot trial[J]. Dermatol Ther (Heidelb), 2018, 8(3): 399-404., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225427584495723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=1., ext=[AuthorCompanyExt(id=1330225427592884332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427584495723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Nursing, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China), AuthorCompanyExt(id=1330225427601272941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427584495723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.南华大学衡阳医学院护理学院,湖南 衡阳 421001)]), AuthorCompany(id=1330225427655798894, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=2., ext=[AuthorCompanyExt(id=1330225427659993199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1330225427668381808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.018, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.018, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.04.018, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.04.018, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1649520000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
外用制剂对非黑素瘤皮肤癌预防及治疗的研究进展
甘蕾萌 1, 2 , 陈裕充 2, *
世界临床药物 | 综述评论 2022,43(4): 464-469
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (4) : 464 -469
外用制剂对非黑素瘤皮肤癌预防及治疗的研究进展
全屏
[Author(id=1330225427764850802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225427844542581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427764850802, language=EN, stringName=Leimeng GAN, firstName=Leimeng, middleName=null, lastName=GAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of Nursing, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China
2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225427920040054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427764850802, language=CN, stringName=甘蕾萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.南华大学衡阳医学院护理学院,湖南 衡阳 421001
2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443, bio={"content":"

甘蕾萌,硕士研究生,护师,研究方向:皮肤肿瘤并发症及护理。

"}, bioImg=null, bioContent=

甘蕾萌,硕士研究生,护师,研究方向:皮肤肿瘤并发症及护理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225427584495723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=1., ext=[AuthorCompanyExt(id=1330225427592884332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427584495723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Nursing, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China), AuthorCompanyExt(id=1330225427601272941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427584495723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.南华大学衡阳医学院护理学院,湖南 衡阳 421001)]), AuthorCompany(id=1330225427655798894, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=2., ext=[AuthorCompanyExt(id=1330225427659993199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1330225427668381808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443)])]), Author(id=1330225427995537528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225428079423610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427995537528, language=EN, stringName=Yuchong CHEN, firstName=Yuchong, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225428154921083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, authorId=1330225427995537528, language=CN, stringName=陈裕充, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225427655798894, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, xref=2., ext=[AuthorCompanyExt(id=1330225427659993199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1330225427668381808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225427009876072, companyId=1330225427655798894, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443)])])]
甘蕾萌1, 2, 陈裕充2, *
作者信息
  • 1.南华大学衡阳医学院护理学院,湖南 衡阳 421001
  • 2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443
通讯作者:
陈裕充,医学博士,副主任医师,研究方向:皮肤肿瘤及毛发移植。
作者简介:

甘蕾萌,硕士研究生,护师,研究方向:皮肤肿瘤并发症及护理。

The progression of topical agents for prevention and treatment of non-melanoma skin cancer
Leimeng GAN1, 2, Yuchong CHEN2, *
Affiliations
  • 1.School of Nursing, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China
  • 2.Department of Dermatological Surgery, Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University, Shanghai 200443, China
出版时间: 2022-04-10 doi: 10.13683/j.wph.2022.04.018
文章导航
收藏切换

非黑素瘤皮肤癌(non-melanoma skin cancer,NMSC)是一种最常见的皮肤恶性肿瘤。随着人口老龄化的进展,其患病率也越来越高。近年来,随着对NMSC发病机制的深入研究,一些新的治疗药物不断出现,各种治疗NMSC及其癌前病变光线性角化病的外用制剂临床研究也越来越完善。通过临床研究,大部分外用制剂的疗效得到进一步肯定。现就治疗光线性角化病和NMSC外用制剂的作用机制、临床应用及不良反应作一综述,为临床针对NMSC的治疗提供更多用药参考。

非黑素瘤皮肤癌  /  光线性角化病  /  外用制剂  /  治疗进展

Non-melanoma skin cancer (NMSC) is one of the most common cutaneous malignancies. With the aging of the population, the prevalence rate is getting higher and higher. With further research for pathogenesis of NMSC, some new topical agents have been emerging, and the clinical research on various topical agents for the treatment of NMSC and its precancerous lesions actinic keratosis has become more and more perfect. Through clinical trials, the efficacy of most external preparations has been further affirmed. This paper reviewed the mechanism, clinical application and side effects of NMSC external preparations for the treatment of actinic keratosis and NMSC to provide more reference for clinical treatment of NMSC.

non-melanoma skin cancer  /  actinic keratosis  /  topical gaents  /  treatment progress
甘蕾萌, 陈裕充. 外用制剂对非黑素瘤皮肤癌预防及治疗的研究进展. 世界临床药物, 2022 , 43 (4) : 464 -469 . DOI: 10.13683/j.wph.2022.04.018
Leimeng GAN, Yuchong CHEN. The progression of topical agents for prevention and treatment of non-melanoma skin cancer[J]. World Clinical Drug, 2022 , 43 (4) : 464 -469 . DOI: 10.13683/j.wph.2022.04.018

参考文献 引证文献
排序方式:
[1]
Ottwell R, Cook C, Greiner B, et al. Lifestyle behaviors and sun exposure among individuals diagnosed with skin cancer: a cross-sectional analysis of 2018 BRFSS data[J]. J Cancer Surviv, 2021, 15(5): 792-798.
[2]
Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review[J]. Br J Dermatol, 2017, 177(2): 350-358.
[3]
Hashim PW, Chen T, Rigel D, et al. Actinic keratosis: current therapies and insights into new treatments[J]. J Drugs Dermatol, 2019, 18(5): s161-166.
[4]
Hsu SH, Gan SD, Nguyen BT, et al. Ablative fractional laser-assisted topical fluorouracil for the treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ: a follow-up study[J]. Dermatol Surg, 2016, 42(9): 1050-1053.
[5]
Collins A, Savas J, Doerfler L. Nonsurgical treatments for nonmelanoma skin cancer[J]. Dermatol Clin, 2019, 37(4): 435-441.
[6]
Jansen MHE, Kessels JPHM, Merks I, et al. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands[J]. Br J Dermatol, 2020, 183(4): 738-744.
[7]
Pomerantz H, Hogan D, Eilers D, et al. Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial[J]. J Am Med Assooc Dermatol, 2015, 151(9): 952-960.
[8]
Heuser CL, Heuser GG, Casagrande J, et al. Peeling with 70% glicolic acid followed by 5% 5-fluorouracil as well as 5% 5-fluorouracil cream are effective methods for the treatment of actinic keratoses on upper limbs: a randomized clinical trial[J]. Dermatol Ther, 2020, 33(3): e13459.
[9]
Jain SK, Kaur M, Kalyani P, et al. Microsponges enriched gel for enhanced topical delivery of 5-fluorouracil[J]. J Microencapsul, 2019, 36(7): 677-691.
[10]
Hussain A, Samad A, Ramzan M, et al. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation[J]. Drug Deliv, 2016, 23(4): 1115-1129.
[11]
Soong LC, Keeling CP. Cryosurgery + 5% 5-fluorouracil for treatment of superficial basal cell carcinoma and bowen's disease[J]. J Cutan Med Surg, 2018, 22(4): 400-404.
[12]
Pomerantz H, Korgavkar K, Lee KC, et al. Validation of photograph-based toxicity score for topical 5-fluorouracil cream application[J]. J Cutan Med Surg, 2016, 20(5): 458-466.
[13]
Maarouf M, Kromenacker BW, Brucks ES, et al. Reducing unpleasant side effects of topical 5-fluorouracil treatment for actinic keratosis: a randomized controlled trial[J]. J Dermatolog Treat, 2020, 31(2): 175-179.
[14]
Petrilli R, Eloy JO, Paschoal JAR, et al. Quantification of 5-FU in skin samples for the development of new delivery systems for topical cancer treatment[J]. Pharmazie, 2018, 73(3): 133-138.
[15]
Ondo AL, Kerner JD, Kerner JV, et al. Treatment of cutaneous squamous cell carcinoma in situ with curettage followed by topical imiquimod 5% cream[J]. Dermatol Surg, 2021, 47(5): 609-612.
[16]
Agozzino M, Russo T, Franceschini C, et al. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial[J]. Curr Med Res Opin, 2019, 35(10): 1785-1792.
[17]
Arits AH, Mosterd K, Essers BA, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial[J]. Lancet Oncol, 2013, 14(7): 647-654.
[18]
Jia HX, He YL. Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial[J]. J Dermatolog Treat, 2020, 31(8): 831-838.
[19]
Sharma M, Sharma G, Singh B. Actinic keratosis and imiquimod: a review of novel carriers and patents[J]. Expert Opin Drug Deliv, 2019, 16(2): 101-112.
[20]
Singer K, Dettmer K, Unger P, et al. Topical diclofenac reprograms metabolism and immune cell infiltration in actinic keratosis[J]. Front Oncol, 2019, 9: 605.
[21]
Čeović R, Petković M, Mokos ZB, et al. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient[J]. Clin Dermatol, 2018, 36(2): 177-187.
[22]
Schmitz L, Gupta G, Segert MH, et al. Diclofenac sodium 3% in hyaluronic acid 2.5% gel significantly diminishes the actinic keratosis area and severity index[J]. Skin Pharmacol Physiol, 2018, 31(4): 206-211.
[23]
Koch F, Salva KA, Wirtz M, et al. Efficacy of cold atmospheric plasma vs diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP)[J]. J Eur Acad Dermatol Venereol, 2020, 34(12): e844-e846.
[24]
Brinkhuizen T, Frencken KJA, Nelemans PJ, et al. The effect of topical diclofenac 3% and calcitriol 3 mg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): a phase Ⅱ, randomized controlled trial[J]. J Am Acad Dermatol, 2016, 75(1): 126-134.
[25]
Heron CE, Feldman SR. Ingenol mebutate and the treatment of actinic keratosis[J]. J Drugs Dermatol, 2021, 20(1): 102-104.
[26]
Lv R, Sun Q. A network meta-analysis of non-melanoma skin cancer (NMSC) treatments: efficacy and safety assessment[J]. J Cell Biochem, 2017, 118(11): 3686-3695.
[27]
Chee JB, Park JT, Kim BR, et al. A case of Bowen's disease successfully treated with ingenol mebutate gel[J]. Ann Deramtol, 2017, 29(4): 523-524.
[28]
Khalfe Y, Rosen T. Ingenol mebutate: expanded utility[J]. J Drugs Dermatol, 2020, 19(2): 156-161.
[29]
Alirezai M, Dupuy P, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses[J]. J Am Acad Dermatol, 1994, 30(3): 447-451.
[30]
Ianhez M, Pinto SA, Miot HA, et al. A randomized, open, controlled trial of tretinoin 0.05% cream vs low-dose oral isotretinoin for the treatment of field cancerization[J]. Int J Dermatol, 2019, 58(3): 365-373.
[31]
Bianchi L, Orlandi A, Campoine E, et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathogical study on a large series of cases[J]. Br J Dermato, 2004, 151(1): 148-156.
[32]
Herold M, Good AJ, Nielson CB. Use of topical and systemic retinoids in solid organ transplant recipients: update and review of the current literature[J]. Dermatol Surg, 2019, 45(12): 1442-1449.
[33]
Ianhez M. Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment[J]. Br J Dermatol, 2018, 179(5): 1026-1027.
[34]
Pommergaard HC, Burcharth J, Rosenberg J, et al. Topical treatment with diclofenac, calcipotriol (vitamin-D3 analog) and difluoromethylornithine (DFMO) does not prevent nonmelanoma skin cancer in mice[J]. Cancer Invest, 2013, 31(2): 92-96.
[35]
Cunningham TJ, Tabacchi M, Eliane JP, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy[J]. J Clin Invest, 2017, 127(1): 106-116.
[36]
Micali G, Lacarrubba F, Bhatt K, et al. Medical approaches to non-melanoma skin cancer[J]. Expert Rev Anticancer Ther, 2013, 13(12): 1409-1421.
[37]
Puviani M, Milani M. Treatment of grade Ⅱ and Ⅲ actinic keratosis lesions with a film-forming medical device containing sunscreen/piroxicam 0.8% and a retinoic acid/glycolic gel: a pilot trial[J]. Dermatol Ther (Heidelb), 2018, 8(3): 399-404.
2022年第43卷第4期
16
6
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.04.018
  • 接收时间:2021-11-09
  • 首发时间:2026-11-19
  • 出版时间:2022-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-11-09
基金
作者信息
    1.南华大学衡阳医学院护理学院,湖南 衡阳 421001
    2.同济大学附属上海市皮肤病医院皮肤外科,上海 200443

通讯作者:

陈裕充,医学博士,副主任医师,研究方向:皮肤肿瘤及毛发移植。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.04.018
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏